A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors
Condition: Her2-positive/Low-expression Urinary and Digestive Tract Tumors Intervention: Drug: BL-M07D1 Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials